SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001718108-23-000017
Filing Date
2023-08-02
Accepted
2023-08-02 07:00:51
Documents
14
Period of Report
2023-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K surf-20230802.htm   iXBRL 8-K 28565
2 EX-99.1 surf-822023xex991.htm EX-99.1 61773
6 surfacelogo.gif GRAPHIC 12839
  Complete submission text file 0001718108-23-000017.txt   253425

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT surf-20230802.xsd EX-101.SCH 1925
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT surf-20230802_lab.xml EX-101.LAB 25850
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT surf-20230802_pre.xml EX-101.PRE 13597
8 EXTRACTED XBRL INSTANCE DOCUMENT surf-20230802_htm.xml XML 2900
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38459 | Film No.: 231133672
SIC: 2836 Biological Products, (No Diagnostic Substances)